A new report from BioCrossroads shows dramatic gains in venture capital funding in Indiana’s life sciences sector. In 2022, 39 companies raised a total of $619 million. This is a 136% increase over 2020’s $262 million and a 65% increase over 2021’s $433 million. Since a comparable number of companies raised capital in those years, the report attributes the gains to an increase in average deal size. Additionally, there was a $124 million funding round for one agtech company, Inari. Had that investment not occurred there still would have been a 14% year-over-year increase.
Publisher at Medical News
Ben is the publisher of Medical News and focuses on the business of healthcare in Kentucky.
Latest posts by Ben Keeton (see all)
- Kentucky-based EmsanaRx, PBC Announces Corporate Name Change to AffirmedRx, PBC - May 17, 2023
- Indiana life sciences companies raise significant venture dollars - April 27, 2023
- Columbus health tech company to power Uber Health’s same day prescription service focused on post-discharge drug needs - April 27, 2023